NIOX Group (LON:NIOX) Announces Quarterly Earnings Results

NIOX Group (LON:NIOX – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported GBX 1.41 EPS for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%.

NIOX Group Price Performance

LON:NIOX opened at GBX 67.44 on Friday. NIOX Group has a 52-week low of GBX 53.84 and a 52-week high of GBX 76. The firm has a market capitalization of £283.82 million, a price-to-earnings ratio of 41.12 and a beta of 0.92. The stock has a fifty day moving average of GBX 65.75 and a 200 day moving average of GBX 61.67. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60.

Get NIOX Group alerts:

About NIOX Group

(Get Free Report)

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.

Featured Stories

• Five stocks we like better than NIOX Group
• Why Concentra’s Quiet Healthcare Business Keeps Winning
• Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
• Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight
• Everyone in AI Is Quietly Copying Palantir’s Playbook

Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.